| Code | CSB-MP004879HU1 |
| Abbreviation | Recombinant Human CD14 protein, partial (Active) |
| MSDS | |
| Size | $118 |
| Order now | |
| Image |
|
| Have Questions? | Leave a Message or Start an on-line Chat |
CD14 serves as the primary pattern recognition receptor for bacterial lipopolysaccharide complexes, making it a critical target for investigating innate immune activation and sepsis pathogenesis. This mammalian-expressed construct spanning residues 20–344 captures the complete extracellular leucine-rich repeat domain responsible for LPS binding, and mammalian post-translational machinery ensures the native glycosylation patterns essential for physiological receptor conformation. Functional ELISA validation demonstrates specific antibody binding with an EC50 of 2.148–2.447 ng/mL, confirming that epitopes remain accessible and properly folded—this quantitative binding profile supports use in therapeutic antibody epitope mapping, competitive inhibition screening to identify blocking candidates, and as a positive control in receptor-ligand interaction assays conducted by ELISA, SPR, or BLI. The protein meets quality thresholds commonly required for antibody development workflows, with >95% purity by SDS-PAGE and endotoxin levels below 1.0 EU/μg.
There are currently no reviews for this product.